| Gene symbol | ROR1 | Synonyms | NTRKR1, dJ537F10.1 | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1p31.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | receptor tyrosine kinase like orphan receptor 1 | ||||
| GTO ID | GTC2958 |
| Trial ID | NCT05274451 |
| Disease | Triple-Receptor Negative Breast Cancer | Lung Non-Small Cell Carcinoma | Lung Carcinoma | Breast Cancer | Relapsed Cancer |
| Altered gene | ROR1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | LYL797 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study to Investigate LYL797 in Adults With Solid Tumors |
| Year | 2022 |
| Country | United States |
| Company sponsor | Lyell Immunopharma, Inc. |
| Other ID(s) | LYL797-101 |
| Cohort 1 | |||||||||
|
|||||||||